Correction to: Pharm Res (2018) 35: 138
There was a miscalculation of coproporphyrin I AUC0-24h in the published article (Volume 35, Number 7). After the correction of AUC0-24h, AUC ratio and R-square were re-calculated. Then, following corrections were made in the abstract, the body, Fig. 3, Fig. 4 and Table 2 in this article. The interpretation of data in this article was not influenced.
The corrected sentences are below.
Page 1.
Abstract
line 20: coproporphyrin I (r2 = 0.78).
line 23: (r2 = 0.48–0.70).
Page 5.
Effect of Rifampicin on the Plasma Concentrations of Coproporphyrin I.
line 4: 2.3- and 3.5-times higher.
Correlations between the AUC0–24h of Endogenous OATP1B Substrates, and of these with the AUC0–24h of Atorvastatin.
line 6: coproporphyrin I (r2 = 0.78).
line 8: atorvastatin (r2 of 0.65, 0.70 and 0.48, respectively).
The corrected Figures and Table appears below.
Page 9.
Fig. 3e
Page 10.
Table 2, line 6 Coproporphyrin I.
Probe drug | Control | +P | +RIF300 | Fold changea | +RIF600 | Fold changea |
|---|---|---|---|---|---|---|
Coproporphyrin I | nd | 16.8 ± 1.6 | 38.1 ± 2.7** | 2.3 ± 0.1 | 57.8 ± 3.8**,†† | 3.5 ± 0.1 |
Fig. 4 a Correlation between AUC0-24h of GCDCA-S and CP-I. b Correlation between AUC0-24h of CP-I and atorvastatin
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11095-018-2416-3
Rights and permissions
About this article
Cite this article
Takehara, I., Yoshikado, T., Ishigame, K. et al. Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers. Pharm Res 36, 55 (2019). https://doi.org/10.1007/s11095-019-2585-8
Published:
DOI: https://doi.org/10.1007/s11095-019-2585-8